RECEPTOR.AI

receptorai-logo

Receptor.ai develops an integral AI-based approach, which combines the best features of protein- and membrane-targeting compounds to create drugs with superior properties. Our AI algorithms are trained on extensive set of public and proprietary experimental data, clinical trials data and the results of in-house numerical simulations. The company's mission is to create superior drugs, which are safe, efficient and successful in clinical trials by developing a next-generation drug discovery platform based on the synergy of AI, computational chemistry and biomimetic technologies, such as organs-on-a-chip.

#SimilarOrganizations #People #Website #More

RECEPTOR.AI

Social Links:

Industry:
Artificial Intelligence Biotechnology Health Care Machine Learning Medical Pharmaceutical

Founded:
2021-02-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.receptor.ai

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
500 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Nginx Euro Amazon Google Apps For Business Amazon S3 CDN


Similar Organizations

emedgene-logo

Emedgene

Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.

Current Employees Featured

sergii-starosyla_image

Sergii Starosyla
Sergii Starosyla CTO & Co-Founder @ RECEPTOR.AI
CTO & Co-Founder
2021-07-01

semen-yesylevskyy_image

Semen Yesylevskyy
Semen Yesylevskyy Chief Scientific Officer @ RECEPTOR.AI
Chief Scientific Officer
2021-03-01

alan-nafiiev_image

Alan Nafiiev
Alan Nafiiev CEO & Founder @ RECEPTOR.AI
CEO & Founder
2021-02-01

Founder


alan-nafiiev_image

Alan Nafiiev

sergii-starosyla_image

Sergii Starosyla

Official Site Inspections

http://www.receptor.ai Semrush global rank: 8.07 M Semrush visits lastest month: 379

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "RECEPTOR.AI"

RECEPTOR.AI - Crunchbase Company Profile & Funding

Receptor.AI is a TechBio company developing generative AI techniques to design first-in-class therapeutics. Its multi-platform ecosystem is built to address โ€ฆSee details»

About Us - RECEPTOR.AI

Receptor.AI is a pioneering TechBio company transforming drug discovery through a validated, AI-powered multiplatform ecosystem.We specialize in developing advanced platforms that address the most complex and previously โ€ฆSee details»

RECEPTOR.AI - LinkedIn

Receptor.AI is a next-generation TechBio company revolutionizing drug discovery with a multiplatform AI-powered ecosystem. We specialize in designing small molecules, peptides, and drug conjugates ...See details»

RECEPTOR.AI 2025 Company Profile: Valuation, โ€ฆ

RECEPTOR.AI was founded in 2021. Where is RECEPTOR.AI headquartered? RECEPTOR.AI is headquartered in London, United Kingdom. What is the size โ€ฆSee details»

RECEPTOR.AI - The Org

Receptor.AI provides an AI-powered drug discovery platform for pharma, biotech and academia that covers the whole drug discovery pipeline. Industries. AI/ML, Biotechnology + 2. Headquarters. Boston, United States.See details»

RECEPTOR.AI - Leadership Team - The Org

The Leadership Team at RECEPTOR.AI is responsible for setting the strategic vision and driving innovation within the company. Comprising key founders and executives with expertise in โ€ฆSee details»

RECEPTOR.AI - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 13, 2024: Funding Round โ€ฆSee details»

Receptor.AI - Products, Competitors, Financials, Employees ...

Receptor.AI has curated a vast library consisting of approximately 4.3 billion in silico-generated small molecule compounds for screening, including 25 known to bind FADS1 (known as โ€ฆSee details»

Alan Nafiiev - RECEPTOR.AI - LinkedIn

I'm the founder and CEO of Receptor.ai, where we're building next-generation AIโ€ฆ · Experience: RECEPTOR.AI · Education: National Technical University โ€ฆSee details»

RECEPTOR.AI - Company info. interviews, news

Nov 14, 2022 This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery Feb. 19, 2024 Receptor.AI, a London-based drug discovery company and NVIDIA Inception member, has successfully integrated NVIDIA โ€ฆSee details»

Receptor.AI aims to democratize drug discovery, making its AI โ€ฆ

Sep 2, 2022 ArtiDock from Receptor.AI: next-generation AI docking that beats DiffDock and AlphaFold-latest Dec 1, 2023 Targeting cryptic pockets with Receptor.AI drug discovery platformSee details»

RECEPTOR.AI | AI-Driven Drug Discovery

40+ proprietary AI models are applied to design novel drugs for precision medicine using proprietary multi-level selectivity assessment Experimental Feedback via Active Learning โ€ฆSee details»

Public launch of the Receptor.AI SaaS platform for drug discovery

Jul 11, 2022 Receptor.AI is delighted to announce the public launch of the SaaS platform for AI-accelerated virtual screening of multi-billion chemical spaces within an hour.. Our platform has โ€ฆSee details»

Receptor.AI โ€œdemocratizesโ€ automated AI solutions for drug โ€ฆ

Jul 18, 2022 Receptor.AI is a British company founded in early 2021 with an R&D department based in Kyiv, Ukraine. Despite the ongoing devastating Russian invasion of Ukraine, the R&D โ€ฆSee details»

RECEPTOR.AI - Org chart - The Org

Explore RECEPTOR.AI's organizational chart. Discover current team members including executives, board members, and advisors.See details»

Receptor.AI - Medium

Mar 14, 2023 Receptor.AI provides an AI-powered drug discovery platform for pharma, biotech and academia that covers the whole drug discovery pipeline in a scalable manner.See details»

Receptor.AI Opens Headquarters in Boston, Strengthening U.S.

Receptor.AI is pleased to announce the expansion of its U.S. presence by establishing a new headquarters in Boston, Massachusetts, while maintaining its existing headquarters in London, โ€ฆSee details»

Nucleic acid spheres for treating capillarisation of liver sinusoidal ...

2 days ago Due to the predominant presence of miRNA in extracellular vesicles, an artificial intelligence (AI) model was developed to discern the active miRNA by collaboratively โ€ฆSee details»

Bridging the AI skills gap in your organization

2 days ago A growth mindset would reframe it: โ€œAI is changing how we workโ€”and I can learn new skills to grow alongside it.โ€ Cultivating a growth mindset within your organization builds โ€ฆSee details»

Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain โ€ฆ

1 day ago Voyager Therapeutics (VYGR) has published groundbreaking research in Molecular Therapy demonstrating how alkaline phosphatase (ALPL) can transport novel AAV capsids โ€ฆSee details»

linkstock.net © 2022. All rights reserved